Monopar Therapeutics Inc
NASDAQ:MNPR
Balance Sheet
Balance Sheet Decomposition
Monopar Therapeutics Inc
Current Assets | 8.9m |
Cash & Short-Term Investments | 8.8m |
Other Current Assets | 119k |
Current Liabilities | 1.4m |
Accounts Payable | 1.4m |
Balance Sheet
Monopar Therapeutics Inc
Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||
Cash & Cash Equivalents |
2
|
9
|
7
|
13
|
17
|
20
|
8
|
7
|
|
Cash Equivalents |
2
|
9
|
7
|
13
|
17
|
20
|
8
|
7
|
|
Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
5
|
0
|
|
Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Current Assets |
2
|
9
|
7
|
13
|
17
|
21
|
13
|
7
|
|
PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Assets |
3
N/A
|
10
+242%
|
7
-26%
|
13
+82%
|
17
+26%
|
21
+22%
|
13
-36%
|
7
-44%
|
|
Liabilities | |||||||||
Accounts Payable |
0
|
0
|
0
|
1
|
1
|
2
|
3
|
2
|
|
Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Current Liabilities |
0
|
0
|
0
|
1
|
1
|
2
|
3
|
2
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Liabilities |
0
N/A
|
0
+417%
|
0
+29%
|
1
+80%
|
1
+64%
|
2
+34%
|
3
+99%
|
2
-44%
|
|
Equity | |||||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
0
|
0
|
22
|
26
|
32
|
41
|
52
|
60
|
|
Additional Paid In Capital |
5
|
28
|
29
|
39
|
48
|
60
|
62
|
66
|
|
Other Equity |
2
|
18
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
3
N/A
|
10
+240%
|
7
-28%
|
13
+83%
|
16
+24%
|
19
+21%
|
10
-47%
|
6
-45%
|
|
Total Liabilities & Equity |
3
N/A
|
10
+242%
|
7
-26%
|
13
+82%
|
17
+26%
|
21
+22%
|
13
-36%
|
7
-44%
|
|
Shares Outstanding | |||||||||
Common Shares Outstanding |
10
|
10
|
10
|
11
|
11
|
13
|
13
|
15
|